Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Varsha Gandhi, PhD, on Ibrutinib

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Oct
22
Today In Oncology
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Remote Expert Case Reviews Identify Opportunities to Improve Cancer Care and Reduce Costs
Phase III RT CHARM Trial Supports Shorter Postmastectomy Radiation Therapy After Breast Reconstruction
Experts Call for Better Quality-of-Life Reporting in Adjuvant Cancer Trials
Bivalent CAR T-Cell Therapy Shows No Delayed Toxicity and Promising Survival in Recurrent Glioblastoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo